Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled ‘Pain Management Devices Market Size, Share, Forecast, & Trends Analysis by Product (Neurostimulation [DBS, TENS, VNS], Infusion Pump, Compression), Pain Type (Surgical, Musculoskeletal, Neuropathic, Cancer), Distribution, End User - Global Forecast to 2031.’
According to this latest publication from Meticulous Research®, the pain management devices market is projected to reach $16.40 billion by 2031, at a CAGR of 5.3% during the forecast period. The growth of the pain management devices market is primarily driven by the rising number of chronic pain cases associated with the geriatric population, the increasing number of surgical procedures, the increasing prevalence of cancer & musculoskeletal diseases, technological advancements in pain management devices, increasing healthcare expenditures, and the increasing number of sports & accident injuries. However, the high costs of pain management devices & therapies and product recalls restrain the growth of this market.
Moreover, partnerships & collaborations by pain management device companies, the integration of digital health technologies into pain management devices, and emerging economies are expected to offer market growth opportunities. However, the lack of awareness about the use of pain management devices in developing countries and the availability of alternative technologies are major challenges in the pain management devices market. Additionally, electrical stimulation devices and wearable pain management devices are prominent trends in the pain management devices market.
Key Players
The key players operating in the pain management devices market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Boston Scientific Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Baxter International, Inc. (U.S.), VirpaxPharmaceuticals, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Rusan Pharma Ltd (India), Grünenthal GmbH (Germany), OMRON Healthcare, Inc. (U.S.), and Nevro Corp. (U.S.).
Pain Management Devices Market: Future Outlook
The pain management devices market is segmented based on Product (Compression Therapy Devices [Bandages, Garments {Stockings, Socks & Sleeves, Wraps & Tapes, Other Garments}, Intermittent/Sequential Pneumatic Compression Pumps, Other Pressure Pumps], Neurostimulation Devices [Deep Brain Stimulation (DBS) Systems, Spinal Cord Stimulation Systems, Transcutaneous Electrical Nerve Stimulation (TENS) Systems, Vagus Nerve Stimulation (VNS) Systems, Other Neurostimulation Devices], Analgesic Infusion Pumps [Intrathecal Infusion Pumps, External Infusion Pumps], Electrotherapy Devices, Ablation Devices, Accessories), Portability (Stationary/Benchtop, Wearable & Implantable), Pain Type (Acute Pain [Injuries, Surgeries], Chronic Pain [Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Chronic Pain Types]), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/E-commerce Platforms), End User (Hospitals & Clinics, Ambulatory Surgical Centers, Physiotherapy Centers, Home Care Settings, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Based on product, the pain management devices market is segmented into compression therapy devices, neurostimulation devices, analgesic infusion pumps, electrotherapy devices, ablation devices, and accessories. In 2024, the compression therapy devices segment is expected to account for the largest share of 28.1% of the pain management devices market. The large market share of this segment can be attributed to technological advancements in compression therapy devices and the increasing demand for compression therapy devices due to their use in treating chronic pain.
Based on portability, the pain management devices market is segmented into stationary/benchtop and wearable & implantable devices. In 2024, the wearable & implantable segment is expected to account for the larger share of the pain management devices market. The segment’s large market share can be attributed to technological advancements in wearable & implantable pain management devices and the benefits offered by these devices, such as the ability to track muscle activity and provide real-time feedback.
Based on pain type, the pain management devices market is segmented into acute pain and chronic pain. In 2024, the chronic pain segment is expected to account for the larger share of the pain management devices market. The large market share of this segment can be attributed to the increasing cases of musculoskeletal diseases, neuropathic cases, and the increasing prevalence of cancer.
Based on distribution channel, the pain management devices market is segmented into hospital pharmacies, retail pharmacies, and online/e-commerce platforms. In 2024, the retail pharmacies segment is expected to account for the largest share of the pain management devices market. The segment’s large share is attributed to the convenience offered by retail pharmacies, the availability of pain management solutions at pharmacy stores, growing awareness about pain management devices, and easy access to retail pharmacies.
Based on end user, the pain management devices market is segmented into hospitals & clinics, ambulatory surgical centers, physiotherapy centers, home care settings, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the pain management devices market. The large market share of this segment can be attributed to the growing number of patient visits to hospitals & clinics for pain management and surgical procedures and the high adoption of pain management devices in hospitals and clinics.
Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of the pain management devices market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
In 2024, North America is expected to account for the largest share of 30.7% of the pain management devices market, followed by Europe and Asia-Pacific. North America’s major market share is attributed to the presence of major pain management device manufacturers, advanced healthcare infrastructure, increasing healthcare expenditure, the increasing prevalence of cancer & musculoskeletal diseases, and the rising number of surgical procedures in the region.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5921
Key Questions Answered in the Report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Tissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More